JP2023121798A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023121798A5 JP2023121798A5 JP2023104924A JP2023104924A JP2023121798A5 JP 2023121798 A5 JP2023121798 A5 JP 2023121798A5 JP 2023104924 A JP2023104924 A JP 2023104924A JP 2023104924 A JP2023104924 A JP 2023104924A JP 2023121798 A5 JP2023121798 A5 JP 2023121798A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- amino acid
- acid sequence
- polynucleotide molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025154255A JP2026009919A (ja) | 2017-07-24 | 2025-09-17 | 抗ｃｄ８抗体およびその使用 |
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762536239P | 2017-07-24 | 2017-07-24 | |
| US62/536,239 | 2017-07-24 | ||
| US201862660902P | 2018-04-20 | 2018-04-20 | |
| US62/660,902 | 2018-04-20 | ||
| JP2020503721A JP7304846B2 (ja) | 2017-07-24 | 2018-07-23 | 抗ｃｄ８抗体およびその使用 |
| PCT/US2018/043343 WO2019023148A1 (en) | 2017-07-24 | 2018-07-23 | ANTI-CD8 ANTIBODIES AND USES THEREOF |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020503721A Division JP7304846B2 (ja) | 2017-07-24 | 2018-07-23 | 抗ｃｄ８抗体およびその使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025154255A Division JP2026009919A (ja) | 2017-07-24 | 2025-09-17 | 抗ｃｄ８抗体およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023121798A JP2023121798A (ja) | 2023-08-31 |
| JP2023121798A5 true JP2023121798A5 (https=) | 2023-12-18 |
| JP7746334B2 JP7746334B2 (ja) | 2025-09-30 |
Family
ID=63143411
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020503721A Active JP7304846B2 (ja) | 2017-07-24 | 2018-07-23 | 抗ｃｄ８抗体およびその使用 |
| JP2023104924A Active JP7746334B2 (ja) | 2017-07-24 | 2023-06-27 | 抗ｃｄ８抗体およびその使用 |
| JP2025154255A Pending JP2026009919A (ja) | 2017-07-24 | 2025-09-17 | 抗ｃｄ８抗体およびその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020503721A Active JP7304846B2 (ja) | 2017-07-24 | 2018-07-23 | 抗ｃｄ８抗体およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025154255A Pending JP2026009919A (ja) | 2017-07-24 | 2025-09-17 | 抗ｃｄ８抗体およびその使用 |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US10730944B2 (https=) |
| EP (1) | EP3658193A1 (https=) |
| JP (3) | JP7304846B2 (https=) |
| KR (2) | KR102880156B1 (https=) |
| CN (1) | CN110997013B (https=) |
| AU (2) | AU2018307744C1 (https=) |
| BR (1) | BR112020001360A2 (https=) |
| CA (1) | CA3070796A1 (https=) |
| CL (1) | CL2020000192A1 (https=) |
| CO (1) | CO2020000680A2 (https=) |
| IL (2) | IL271901B2 (https=) |
| MA (1) | MA49683A (https=) |
| MX (2) | MX2020000916A (https=) |
| MY (1) | MY197688A (https=) |
| PH (1) | PH12020550008A1 (https=) |
| SG (1) | SG11202000073XA (https=) |
| WO (1) | WO2019023148A1 (https=) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20150131208A (ko) | 2013-03-13 | 2015-11-24 | 이미지냅 인코포레이티드 | Cd８에의 항원 결합 구조체들 |
| US11254744B2 (en) | 2015-08-07 | 2022-02-22 | Imaginab, Inc. | Antigen binding constructs to target molecules |
| EP4649966A3 (en) | 2016-12-01 | 2026-02-18 | Regeneron Pharmaceuticals, Inc. | Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging |
| US11266745B2 (en) | 2017-02-08 | 2022-03-08 | Imaginab, Inc. | Extension sequences for diabodies |
| SG11202000073XA (en) | 2017-07-24 | 2020-02-27 | Regeneron Pharma | Anti-cd8 antibodies and uses thereof |
| US11162079B2 (en) | 2019-05-10 | 2021-11-02 | The Regents Of The University Of California | Blood type O Rh-hypo-immunogenic pluripotent cells |
| EP3886946A1 (en) | 2019-06-05 | 2021-10-06 | Regeneron Pharmaceuticals, Inc. | Devices and methods for precision dose delivery |
| AU2020349462A1 (en) | 2019-09-16 | 2022-03-03 | Regeneron Pharmaceuticals, Inc. | Radiolabeled MET binding proteins for immuno-PET imaging |
| AU2021206233A1 (en) * | 2020-01-10 | 2022-08-11 | Fusion Pharmaceuticals Inc. | Sustained immunotherapy |
| CN113563473A (zh) * | 2020-04-29 | 2021-10-29 | 三生国健药业（上海）股份有限公司 | 四价双特异性抗体、其制备方法和用途 |
| CN111413298A (zh) * | 2020-05-27 | 2020-07-14 | 深圳市天安至远传感科技有限公司 | 一种光纤表面等离子体共振传感器、制备方法及检测系统 |
| CN116723857A (zh) * | 2020-07-21 | 2023-09-08 | 苏州智核生物医药科技有限公司 | Cd8结合多肽及其用途 |
| CN116194480A (zh) | 2020-08-13 | 2023-05-30 | 百时美施贵宝公司 | 将il-2重定向到目的靶细胞的方法 |
| CN114112868B (zh) * | 2020-08-26 | 2024-12-13 | 上海睿昂基因科技股份有限公司 | 一种用于监测肿瘤相关免疫微环境的流式细胞术试剂盒及监测方法 |
| TW202231292A (zh) * | 2020-10-13 | 2022-08-16 | 美商健生生物科技公司 | 用於調節分化簇ｉｖ及／或ｖｉｉｉ的經生物工程改造之ｔ細胞介導之免疫力、材料、及其他方法 |
| KR20230112632A (ko) * | 2020-10-23 | 2023-07-27 | 애셔 바이오테라퓨틱스, 인크. | 면역 세포 기능을 조절하기 위한 cd8 항원 결합 분자와의 융합 |
| MX2023008081A (es) | 2021-01-11 | 2023-09-12 | Sana Biotechnology Inc | Uso de vectores virales dirigidos a cd8. |
| KR20240028975A (ko) | 2021-04-08 | 2024-03-05 | 사나 바이오테크놀로지, 인크. | Cd8-특이적 항체 구조체들 및 이의 조성물 |
| IL308609A (en) | 2021-05-19 | 2024-01-01 | Asher Biotherapeutics Inc | IL-21 polypeptides and target constructs |
| AU2022282609A1 (en) * | 2021-05-26 | 2023-11-30 | Oxford Biotherapeutics Ltd | Pharmaceutical combination comprising an anti-cd205 antibody and an immune checkpoint inhibitor |
| CN114230665B (zh) * | 2021-06-23 | 2024-03-22 | 苏州智核生物医药科技有限公司 | CD8α结合多肽及其用途 |
| US20250101126A1 (en) | 2021-08-05 | 2025-03-27 | Go Therapeutics, Inc. | Anti-glyco-muc4 antibodies and their uses |
| EP4396232A1 (en) | 2021-09-03 | 2024-07-10 | Go Therapeutics, Inc. | Anti-glyco-lamp1 antibodies and their uses |
| CN118354789A (zh) | 2021-09-03 | 2024-07-16 | Go医疗股份有限公司 | 抗糖-cMET抗体及其用途 |
| WO2023114949A1 (en) | 2021-12-16 | 2023-06-22 | Sana Biotechnology, Inc. | Methods and systems of particle production |
| EP4463135A2 (en) | 2022-01-10 | 2024-11-20 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2023150647A1 (en) | 2022-02-02 | 2023-08-10 | Sana Biotechnology, Inc. | Methods of repeat dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2023193015A1 (en) | 2022-04-01 | 2023-10-05 | Sana Biotechnology, Inc. | Cytokine receptor agonist and viral vector combination therapies |
| EP4556493A1 (en) | 2022-07-11 | 2025-05-21 | Genuv Inc. | Cytokine fusion protein |
| WO2024026377A1 (en) | 2022-07-27 | 2024-02-01 | Sana Biotechnology, Inc. | Methods of transduction using a viral vector and inhibitors of antiviral restriction factors |
| CN115337413B (zh) * | 2022-08-08 | 2023-08-22 | 中国科学院近代物理研究所 | 一种针对非小细胞肺癌诊断的放射性分子探针的制备及应用 |
| WO2024040194A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
| US20260055146A1 (en) | 2022-08-24 | 2026-02-26 | Sana Biotechnology, Inc. | Delivery of heterologous proteins |
| WO2024064838A1 (en) | 2022-09-21 | 2024-03-28 | Sana Biotechnology, Inc. | Lipid particles comprising variant paramyxovirus attachment glycoproteins and uses thereof |
| CN115746137A (zh) * | 2022-10-13 | 2023-03-07 | 华道(上海)生物医药有限公司 | 一种抗cd8抗体及其应用 |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| WO2024119157A1 (en) | 2022-12-02 | 2024-06-06 | Sana Biotechnology, Inc. | Lipid particles with cofusogens and methods of producing and using the same |
| EP4680641A1 (en) | 2023-03-16 | 2026-01-21 | Itabmed Co., Ltd. | Multispecific antigen binding proteins and uses thereof |
| WO2024220597A2 (en) | 2023-04-18 | 2024-10-24 | Sana Biotechnology, Inc. | Digital droplet based assay for detecting replication competent lentiviral vector |
| EP4716750A1 (en) | 2023-05-23 | 2026-04-01 | Sana Biotechnology, Inc. | Tandem fusogens and related lipid particles |
| AU2024279278A1 (en) | 2023-05-31 | 2025-12-18 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| CN119684430A (zh) * | 2023-09-22 | 2025-03-25 | 深圳华大生命科学研究院 | 一种抗原多肽、由其制备的抗体及其在检测cd8中的应用 |
| WO2025076113A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Ionizable cationic lipids with conserved spacing and lipid nanoparticles |
| US20250127728A1 (en) | 2023-10-05 | 2025-04-24 | Capstan Therapeutics, Inc. | Constrained Ionizable Cationic Lipids and Lipid Nanoparticles |
| WO2025128807A1 (en) | 2023-12-13 | 2025-06-19 | Amgen Inc. | Radiolabeled compounds for the detection of steap1 |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
| US20250302763A1 (en) | 2024-02-22 | 2025-10-02 | Capstan Therapeutics, Inc. | Immune engineering amplification |
| WO2025184529A1 (en) | 2024-03-01 | 2025-09-04 | Sana Biotechnology, Inc. | Viral particles with fusogen display and related compositions and methods |
| WO2025217452A1 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| WO2025217454A2 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Ionizable cationic lipids and lipid nanoparticles |
| CN118745228B (zh) * | 2024-07-04 | 2025-09-23 | 杭州百凌生物科技有限公司 | 一种抗cd8抗体及其应用 |
Family Cites Families (66)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4680338A (en) | 1985-10-17 | 1987-07-14 | Immunomedics, Inc. | Bifunctional linker |
| US5332567A (en) | 1989-08-24 | 1994-07-26 | Immunomedics | Detection and treatment of infections with immunoconjugates |
| US5428156A (en) | 1993-04-02 | 1995-06-27 | Associated Universities, Inc. | Synthesis of macrocyclic polyaminocarboxylates and their use for preparing stable radiometal antibody immunoconjugates for therapy, spect and pet imaging |
| US7087411B2 (en) | 1999-06-08 | 2006-08-08 | Regeneron Pharmaceuticals, Inc. | Fusion protein capable of binding VEGF |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| JP2006502091A (ja) | 2002-03-01 | 2006-01-19 | イミューノメディクス、インコーポレイテッド | クリアランス速度を高めるための二重特異性抗体点変異 |
| US20100111856A1 (en) | 2004-09-23 | 2010-05-06 | Herman Gill | Zirconium-radiolabeled, cysteine engineered antibody conjugates |
| US20080193376A1 (en) | 2004-10-28 | 2008-08-14 | The General Hospital Corporation | Methods of Enhanced Detection and Therapy of Inflamed Tissues Using Immune Modulation |
| WO2006050058A2 (en) | 2004-10-28 | 2006-05-11 | The General Hospital Corporation | Methods of detection and therapy of inflamed tissues using immune modulation |
| US8889100B2 (en) | 2007-01-11 | 2014-11-18 | Immunomedics, Inc. | Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules |
| WO2008124467A1 (en) | 2007-04-06 | 2008-10-16 | Macrocyclics | Bifunctional hydroxamic acid ligands and method of synthesis |
| WO2009085879A2 (en) | 2007-12-21 | 2009-07-09 | Schering Corporation | C20-c21 substituted glucocorticoid receptor agonists |
| US20090297439A1 (en) | 2008-06-02 | 2009-12-03 | Metheresis Translational Research Sa, | Anti-met monoclonal antibody, fragments and derivatives thereof for use in tumor diagnosis, corresponding compositions and kits |
| WO2009149382A2 (en) * | 2008-06-06 | 2009-12-10 | Baylor Research Institute | Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells |
| NZ701208A (en) | 2010-06-03 | 2016-05-27 | Genentech Inc | Immuno-pet imaging of antibodies and immunoconjugates and uses thereof |
| BR112013014527A2 (pt) | 2010-12-20 | 2017-03-07 | Genentech Inc | anticorpo isolado, ácido nucleico isolado, célula hospedeira, método para produzir um anticorpo, imunoconjugado, formulação farmacêutica, uso do imunoconjugado, método para tratamento de um indivíduo que tem um câncer positivo para mesotelina, para inibição de proliferação de uma célula positiva para mesotelina, para detecção de mesotelina humana em uma amostra biológica e para detectar um câncer positivo para mesotelina |
| US10668162B2 (en) | 2012-01-06 | 2020-06-02 | Linxis B.V. | Method for preparing cell targeting conjugates, and the complexes obtained |
| WO2013138696A1 (en) | 2012-03-16 | 2013-09-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Zirconium-89 complexes, methods of labeling cells, labeled cells, kits, and methods of use thereof |
| AR090549A1 (es) | 2012-03-30 | 2014-11-19 | Genentech Inc | Anticuerpos anti-lgr5 e inmunoconjugados |
| US9056910B2 (en) | 2012-05-01 | 2015-06-16 | Genentech, Inc. | Anti-PMEL17 antibodies and immunoconjugates |
| CN104540519B (zh) | 2012-05-21 | 2018-06-01 | 基因泰克公司 | 抗Ly6E抗体和免疫缀合物及使用方法 |
| WO2014025828A1 (en) * | 2012-08-06 | 2014-02-13 | The Regents Of The University Of California | Engineered antibody fragments for targeting and imaging cd8 expression in vivo |
| WO2014066733A2 (en) | 2012-10-25 | 2014-05-01 | Life Technologies Corporation | Methods and compositions for enzyme-mediated site-specific radiolabeling of glycoproteins |
| EP2740726A1 (en) | 2012-12-07 | 2014-06-11 | 3B Pharmaceuticals GmbH | Neurotensin receptor ligands |
| TWI635098B (zh) | 2013-02-01 | 2018-09-11 | 再生元醫藥公司 | 含嵌合恆定區之抗體 |
| ES2673583T3 (es) | 2013-02-28 | 2018-06-22 | National Cancer Center | Anticuerpo contra fibrina insoluble |
| KR20150131208A (ko) | 2013-03-13 | 2015-11-24 | 이미지냅 인코포레이티드 | Cd８에의 항원 결합 구조체들 |
| JP6436965B2 (ja) | 2013-03-14 | 2018-12-12 | ジェネンテック， インコーポレイテッド | 抗ｂ７−ｈ４抗体及びイムノコンジュゲート |
| WO2014159087A1 (en) | 2013-03-14 | 2014-10-02 | The Board Of Trustees Of The Leland Stanford Junior University | Radiolabeled anti-glypican-3 immunoconjugates for immuno-pet imaging of hepatocellular carcinoma |
| US20170035917A1 (en) | 2013-06-10 | 2017-02-09 | Millennium Pharmaceuticals, Inc. | Methods of treatment of cancer |
| TWI725931B (zh) | 2013-06-24 | 2021-05-01 | 美商建南德克公司 | 抗ｆｃｒｈ５抗體 |
| FR3008408B1 (fr) | 2013-07-11 | 2018-03-09 | Mc Saf | Nouveaux conjugues anticorps-medicament et leur utilisation en therapie |
| AU2014332442B2 (en) | 2013-08-26 | 2019-12-19 | Biontech Research And Development, Inc. | Nucleic acids encoding human antibodies to Sialyl-Lewis |
| WO2015061209A1 (en) | 2013-10-21 | 2015-04-30 | Genentech, Inc. | ANTI-Ly6E ANTIBODIES AND METHODS OF USE |
| SMT201900338T1 (it) | 2013-11-19 | 2019-07-11 | Fredax Ab | Anticopri anti-callicreina-2 umanizzato |
| SG11201604784XA (en) | 2013-12-13 | 2016-07-28 | Genentech Inc | Anti-cd33 antibodies and immunoconjugates |
| TWI680138B (zh) * | 2014-01-23 | 2019-12-21 | 美商再生元醫藥公司 | 抗ｐｄ-ｌ１之人類抗體 |
| TWI681969B (zh) * | 2014-01-23 | 2020-01-11 | 美商再生元醫藥公司 | 針對ｐｄ-１的人類抗體 |
| GB201403875D0 (en) | 2014-03-05 | 2014-04-16 | Cantargia Ab | Novel antibodies and uses thereof |
| EP3131585B1 (en) | 2014-03-19 | 2020-07-15 | Universität Zürich | Multidentate bifunctional chelating agents for radionuclide complexation in diagnostics and therapy |
| WO2015179658A2 (en) | 2014-05-22 | 2015-11-26 | Genentech, Inc. | Anti-gpc3 antibodies and immunoconjugates |
| RU2743781C2 (ru) | 2014-06-10 | 2021-02-25 | 3Б Фармасьютикалз Гмбх | Конъюгат, содержащий лиганд рецепторов нейротензина, и его применение |
| CN106459202A (zh) | 2014-06-11 | 2017-02-22 | 豪夫迈·罗氏有限公司 | 抗LgR5抗体及其用途 |
| GB201413913D0 (en) | 2014-08-06 | 2014-09-17 | Cantargia Ab | Novel antibodies and uses thereof |
| PT3177640T (pt) | 2014-08-08 | 2020-08-31 | Univ Leland Stanford Junior | Agentes pd-1 de alta afinidade e métodos de utilização |
| MA40579A (fr) | 2014-09-12 | 2016-03-17 | Genentech Inc | Anticorps anti-cll-1 et immunoconjugués |
| WO2016040724A1 (en) | 2014-09-12 | 2016-03-17 | Genentech, Inc. | Anti-b7-h4 antibodies and immunoconjugates |
| LT3191135T (lt) | 2014-09-12 | 2020-11-25 | Genentech, Inc. | Anti-her2 antikūnai ir imunokonjugatai |
| CN104360049B (zh) * | 2014-09-22 | 2016-08-17 | 重庆医科大学附属儿童医院 | 一种t淋巴细胞免疫分型的方法和试剂盒 |
| US9980930B2 (en) | 2014-10-16 | 2018-05-29 | The University Of Melbourne | Imaging composition and uses thereof |
| CA2969067A1 (en) | 2014-11-25 | 2016-06-02 | Bristol-Myers Squibb Company | Novel pd-l1 binding polypeptides for imaging |
| WO2016144873A2 (en) | 2015-03-06 | 2016-09-15 | Mayo Foundation For Medical Education And Research | Methods for cell labeling and medical imaging |
| NL2014423B1 (en) | 2015-03-09 | 2016-10-13 | Linxis B V | Method for removing weakly bound functional moieties from cell targeting conjugates. |
| US12048753B2 (en) | 2015-10-01 | 2024-07-30 | Whitehead Institute For Biomedical Research | Labeling of antibodies |
| WO2017087826A1 (en) | 2015-11-18 | 2017-05-26 | Memorial Sloan Kettering Cancer Center | Systems, methods, and compositions for imaging androgen receptor axis activity in carcinoma, and related therapeutic compositions and methods |
| HRP20210644T8 (hr) | 2016-05-19 | 2021-06-25 | Bristol-Myers Squibb Company | Imunomodulatori za pet-snimanje |
| JP2019517565A (ja) | 2016-06-06 | 2019-06-24 | リンクシス ベー．フェー． | 細胞標的化結合体 |
| AU2017281940C1 (en) | 2016-06-24 | 2024-11-07 | University Of Iowa Research Foundation | Compositions and methods of treating melanoma |
| EP3266465A1 (en) | 2016-07-06 | 2018-01-10 | Julius-Maximilians-Universität Würzburg | Immune complexes |
| US11633506B2 (en) | 2016-07-18 | 2023-04-25 | Wisconsin Alumni Research Foundation | Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunotherapies |
| EP3484513B1 (en) | 2016-07-18 | 2023-06-07 | Wisconsin Alumni Research Foundation | Radiohalogenated agents for combined cancer therapy |
| US11168148B2 (en) | 2016-09-07 | 2021-11-09 | The Regents Of The University Of California | Antibodies to oxidation-specific epitopes |
| EP4026849A1 (en) | 2016-09-26 | 2022-07-13 | Ensemble Group Holdings | Methods of assessing and treating cancer in subjects having dysregulated lymphatic systems using a combination of vegfr-3 and pd-1 or pd-l1 inhibitors |
| US11103603B2 (en) | 2016-10-20 | 2021-08-31 | The University Of North Carolina At Chapel Hill | 18F-labeled compounds for PET imaging and uses thereof |
| EP4464334A3 (en) | 2016-11-07 | 2025-01-08 | VIDAC Pharma Ltd. | Use of compounds for treating hk2-expressing cancers |
| SG11202000073XA (en) | 2017-07-24 | 2020-02-27 | Regeneron Pharma | Anti-cd8 antibodies and uses thereof |
-
2018
- 2018-07-23 SG SG11202000073XA patent/SG11202000073XA/en unknown
- 2018-07-23 KR KR1020207004275A patent/KR102880156B1/ko active Active
- 2018-07-23 CN CN201880053140.1A patent/CN110997013B/zh active Active
- 2018-07-23 KR KR1020257036265A patent/KR20250162627A/ko active Pending
- 2018-07-23 MX MX2020000916A patent/MX2020000916A/es unknown
- 2018-07-23 MY MYPI2020000164A patent/MY197688A/en unknown
- 2018-07-23 WO PCT/US2018/043343 patent/WO2019023148A1/en not_active Ceased
- 2018-07-23 MA MA049683A patent/MA49683A/fr unknown
- 2018-07-23 US US16/043,048 patent/US10730944B2/en active Active
- 2018-07-23 IL IL271901A patent/IL271901B2/en unknown
- 2018-07-23 IL IL316355A patent/IL316355A/en unknown
- 2018-07-23 BR BR112020001360-9A patent/BR112020001360A2/pt unknown
- 2018-07-23 JP JP2020503721A patent/JP7304846B2/ja active Active
- 2018-07-23 AU AU2018307744A patent/AU2018307744C1/en active Active
- 2018-07-23 CA CA3070796A patent/CA3070796A1/en active Pending
- 2018-07-23 EP EP18752377.4A patent/EP3658193A1/en active Pending
-
2020
- 2020-01-07 PH PH12020550008A patent/PH12020550008A1/en unknown
- 2020-01-22 CO CONC2020/0000680A patent/CO2020000680A2/es unknown
- 2020-01-23 MX MX2024014445A patent/MX2024014445A/es unknown
- 2020-01-23 CL CL2020000192A patent/CL2020000192A1/es unknown
- 2020-06-26 US US16/914,112 patent/US11525001B2/en active Active
-
2022
- 2022-10-26 US US18/049,972 patent/US12077587B2/en active Active
-
2023
- 2023-06-27 JP JP2023104924A patent/JP7746334B2/ja active Active
-
2024
- 2024-07-23 US US18/781,469 patent/US20240409637A1/en active Pending
-
2025
- 2025-08-05 AU AU2025213570A patent/AU2025213570A1/en active Pending
- 2025-09-17 JP JP2025154255A patent/JP2026009919A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023121798A5 (https=) | ||
| JP2022106952A5 (https=) | ||
| JP2024109678A5 (https=) | ||
| JP2022191383A5 (https=) | ||
| JP2026009919A5 (https=) | ||
| JP2023093753A5 (https=) | ||
| IL316355A (en) | Anti-CD8 antibodies and their uses | |
| JP2022523442A5 (https=) | ||
| JP2019107018A5 (https=) | ||
| TW201815825A (zh) | 經修飾之抗原結合fab片段及包含其之抗原結合分子 | |
| JP2020505017A5 (https=) | ||
| IL309975A (en) | Antibodies against C5 and their uses | |
| CN115461368A (zh) | 抗人白细胞介素-4受体α抗体及其制备方法和应用 | |
| CA2492671A1 (en) | Humanized antibody and process for preparing same | |
| RU2008143356A (ru) | Очистка антитела | |
| IL273841B1 (en) | Antibodies targeting cd137 and methods of use thereof | |
| RU2012127381A (ru) | Гуманизированные антитела против il-10 для лечения системной красной волчанки (sle) | |
| CA2189015A1 (en) | Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases | |
| JP2018536393A5 (https=) | ||
| JP2025067915A5 (https=) | ||
| JP2020537520A5 (https=) | ||
| JP2013543384A5 (https=) | ||
| JP2010524435A5 (https=) | ||
| HRP20181047T1 (hr) | Protutijela protiv kemokina pan-elr+ cxc | |
| JP2025016538A5 (https=) |